Evolving Trends and Impact of Waitlist Transfusion on Recipient Outcomes Following Heart Transplantation
There is a lower incidence of waitlist transfusion among transplant recipients under the 2018 allocation system. Waitlist transfusion is not an independent predictor of adverse posttransplant outcomes but rather a marker of the patient's clinical condition. ECMO, Impella, and pretransplant dialysis are strong predictors of waitlist transfusion.
Authors
- Michael A. Mathier
- Luke A. Ziegler (ORCID: https://orcid.org/0000-0002-2651-9316)
- Mary Keebler (ORCID: https://orcid.org/0000-0002-9797-6995)
- Nidhi Iyanna
- David Kaczorowski
- Yeahwa Hong (ORCID: https://orcid.org/0000-0001-9963-6970)
- Ander Dorken‐Gallastegi (ORCID: https://orcid.org/0000-0003-3566-5937)
- Nicholas R. Hess (ORCID: https://orcid.org/0000-0002-5798-5432)
- Gavin Hickey (ORCID: https://orcid.org/0000-0002-0547-4921)
- Mohamed Abdullah
Institutions
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1111/ctr.15422
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Heart, Lung, and Blood Institute